China Pharma News: BMS/BeiGene Spat Intensifies; US Senators Call…
The latest news from Chinese pharma and biotech, including BMS’ attempts to pull out of its Abraxane supply deal with local player BeiGene; a…
Tagged with Roundup
India Pharma News: Piramal Demerges Pharma Business; Lundbeck…
The latest news from Indian pharm and healthcare, including Piramal Enterprises’ decision to demerge and list its pharma arm, the country’s 15…
Russia Pharma News: WHO Sputnik V Suspension; Vaccine Hesitancy…
The latest news from Russian healthcare and life sciences, including the WHO’s decision to suspend the approval process for the country’s Sputnik…
China News Roundup: Sinopharm Looks to mRNA Vaccines; Hong Kong…
The latest news from Chinese pharma and biotech, including news that state-owned Sinopharm is now developing its own mRNA vaccine; an update on Hong…
CEE Pharma News: EU5/CEE Healthcare Disparity; Novavax’s…
The latest pharma news from Central and Eastern Europe (CEE), including a new report on the disparities between the region’s healthcare systems and…
South Africa Pharma News: Vaccines Made in Africa to Stay in…
A roundup of the latest news from South African pharma, including Aspen’s impressive annual growth, Adcock Ingram’s full year profit drop, and…
China Pharma News: Fosun Sales up 20%; MNC Price Manoeuvres Lead…
The latest news from Chinese pharma, including Fosun Pharma’s 2021 interim results; how AstraZeneca, Bayer, Eli Lilly, Merck & Co., Novartis,…
Ireland Pharma News: Abbott Splashes the Cash on New R&D…
The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch & Lomb’s EUR 90 million…
Spain Pharma News: Grifols Invests in Nigerian Manufacturing;…
The latest from Spanish pharma, including the Patent and Trademark Office’s warning of the importance of IP protection for medical advancements,…
China Pharma Roundup: Sinopharm Tops Brand Value Rankings;…
The latest news from the Chinese pharmaceutical industry, including recent deals between domestic pharma giant Simcere and German biotech Vivoryon in…
US Health Policy: FDA Calls for Federal Investigation of Itself…
The latest from US health care policy, including the Senate budget deal funding for a range of major health care priorities; Biden’s proposed…
South Africa Pharma News: Ramaphosa Slams Big Pharma; Aspen Gets…
The latest from South African pharma, including President Ramaphosa’s blunt criticism of Big Pharma, Aspen’s reception of USD 700 million in…
